Table 2. Adverse events after neoadjuvant therapy.
| Events | Patients (n=22) | |
|---|---|---|
| Any grade, n (%) | Grade ≥3, n (%) | |
| Diarrhea | 21 (95.5) | 4 (18.2) |
| Hand-foot syndrome | 21 (95.5) | 1 (4.5) |
| Loss of appetite | 17 (77.3) | 0 |
| Rash | 12 (54.5) | 2 (9.1) |
| Asthenia | 6 (27.3) | 0 |
| ALT/AST increased | 3 (13.6) | 0 |
| Platelet count decreased | 3 (13.6) | 0 |
| Insomnia | 3 (13.6) | 0 |
| Creatinine increased | 2 (9.1) | 0 |
| Nausea/vomiting | 2 (9.1) | 0 |
| Triglycerides increased | 2 (9.1) | 0 |
| Weight loss | 2 (9.1) | 0 |
| Cardiotoxicity | 1 (4.5) | 0 |
ALT, alanine transaminase; AST, aspartate transaminase.